TL;DR
This paper introduces BLISS, a novel framework that enables large-scale proteome-wide association studies (PWAS) using only publicly available summary-level protein quantitative trait loci (pQTL) data. This approach overcomes limitations of traditional methods that require individual-level proteomic data, paving the way for more comprehensive multi-ancestry analyses and drug target discovery.
What Problem Does This Paper Address?
Understanding the link between proteins and complex diseases is crucial for identifying therapeutic targets. Proteome-wide association studies (PWAS) are a powerful tool for this, but traditional methods rely on individual-level proteomic data for model training. This is a significant bottleneck due to data privacy concerns and the increasing availability of summary-level pQTL data from large biobanks. The authors address this by developing a method that can train accurate protein imputation models using only summary statistics, thus democratizing PWAS and enabling multi-ancestry analyses.
Methods
The core innovation is the BLISS (Biomarker expression Level Imputation using Summary Statistics) framework. BLISS trains protein imputation models using only pQTL summary statistics and a linkage disequilibrium (LD) reference panel. Key aspects include:
- Summary-level training: BLISS avoids the need for individual-level proteomic data by generating pseudo-training, pseudo-tuning, and pseudo-ensemble learning datasets from summary statistics.
- Penalized regression: A penalized regression framework is used to train models, with parameters tuned by maximizing predictive R-squared in a pseudo-tuning setup.
- Robust pseudo-ensemble learning: BLISS combines predictions from models trained with varying LD clumping thresholds (r²) to improve robustness.
- Super learner integration: For non-European ancestries, BLISS integrates European-trained models with smaller, ancestry-specific datasets to improve prediction accuracy.
Datasets
- pQTL Data:
- UK Biobank (UKB)
- deCODE genetics
- Atherosclerosis Risk in Communities (ARIC) study
- GWAS Data:
- Million Veteran Program (MVP)
- Global Biobank Meta-analysis Initiative (GBMI)
- FinnGen
- IEU OpenGWAS
- Biobank Japan (BBJ)
- Proteomic Platforms:
- SomaScan v4
- Olink Explore 3072
Key Insights and Ideas
- Summary statistics are sufficient: The study demonstrates that accurate protein imputation models can be built using only summary-level pQTL data, overcoming a major hurdle in PWAS.
- Multi-ancestry PWAS is feasible: BLISS enables large-scale, multi-ancestry PWAS, revealing ancestry-specific protein-phenotype associations and improving our understanding of disease mechanisms across diverse populations.
- Platform complementarity: Different proteomic platforms (Olink and SomaScan) capture distinct biological insights, and combining them provides a more comprehensive view of disease pathways.
- Drug target prioritization: BLISS models show promise in identifying and prioritizing potential drug targets, outperforming other methods in some aspects.
Key Results
- BLISS models achieved comparable predictive R² to standard PWAS models trained on individual-level data, especially at higher protein expression heritability.
- The framework successfully developed large-scale European PWAS models covering 5,779 unique proteins.
- Super learner integration significantly improved predictive performance for non-European ancestries (e.g., a 3.6-fold increase in median predictive R² for Asian models with low initial accuracy).
- BLISS identified 32,072 significant protein-phenotype associations in the European cohort and 2,063 in the African cohort from MVP data.
- A comparison with TWAS, MR, and colocalization showed that BLISS identified a substantial number of unique associations and a higher number of therapeutically validated drug targets.
- Cross-platform comparisons revealed both shared and distinct associations, highlighting the complementary nature of Olink and SomaScan.
Limitations and Future Work
- Super learner dependency: The current super learner framework for non-European ancestries requires small-scale individual-level pQTL data, deviating from the purely summary-statistic-based nature of BLISS. Future work aims to develop super learning techniques that rely solely on summary statistics.
- Causality interpretation: PWAS associations do not necessarily establish causality due to complex genomic architecture and potential confounding factors like LD. Careful interpretation is crucial, and PWAS is best used as a hypothesis-generating tool.
- Proteome coverage: Existing proteomic platforms do not measure the entire proteome, meaning the true causal protein might not always be captured.
- Asian subpopulation heterogeneity: Due to limited sample sizes, Asian ancestry samples were grouped, potentially not capturing full genetic heterogeneity. Future work will incorporate larger sample sizes and more fine-grained, population-specific models as proteomic data resources expand.
Summary updated